# Mitokyne, Inc. — Form D

Mitokyne, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-17. The offering totals $45.0M, of which $5.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-10-17
- Form: D
- Accession: 0001589455-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $5.2M
- Remaining: $39.8M
- Investors: 4
- Date of first sale: 2013-10-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-204791

## Issuer

- Name: Mitokyne, Inc.
- CIK: 0001589455
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: C/O MPM CAPITAL, 200 CLARENDON STREET, BOSTON, MA, 02116
- Phone: 617-425-9200

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Richard Aldrich | Director | CAMBRIDGE, MA |
| Sakae Asanuma | Director | Cambridge, MA |
| Ansbert Gadicke | Director | Morristown, NJ |
| Kazumi Shiosaki | Director | Watertown, MA |
| David Cordo | Executive Officer | Cambridge, MA |
| Kazumi Shiosaki | Executive Officer | Watertown, MA |

## More

- [CIK 1589455 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1589455&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001589455-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.